MPC Therapeutics

📍 Plan-les-Ouates, Switzerland🗓 Founded 2018👥 5 employees💰 Last funded Dec 2022
Biotechnology Research🌐 mpc-therapeutics.com
Website LinkedIn
At MPC Therapeutics, we are convinced that mitochondria, the small organelles at the core of the cell's metabolism, represent untapped therapeutic targets. Headquartered in Switzerland, our startup is focused on cellular rejuvenation to improve the performance of cell therapies and treat degenerative pathologies. Our novel approach uses proprietary first-in-class small molecules that specifically target mitochondria to trigger metabolic reprogramming. Visit our website for more info.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in MPC Therapeutics?
MPC Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did MPC Therapeutics last raise funding?
The most recent investment in MPC Therapeutics recorded on gritt.io was in December 2022.
When was MPC Therapeutics founded?
MPC Therapeutics was founded in 2018.
What industry is MPC Therapeutics in?
MPC Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MPC Therapeutics based?
MPC Therapeutics is headquartered in Plan-les-Ouates, Switzerland.